Skip to main content

Table 2 Indication to IMPELLA , MCS-related management and outcomes

From: The contemporary role of Impella in a comprehensive mechanical circulatory support program: a single institutional experience

Patient ID Indication to implantation Rationale for impella’s implantation Devices implanted Hemolysis Anticoagulation Major bleeding Outcome
IMP1 CSMI (STEMI) Circulatory support, LV venting IMPELLA 2.5, IABP No UFH 25 U/ml (purge fluid) No LVAD
IMP2 Cardiogenic shock (arrhytmia) LV venting during ECMO in severe AI IMPELLA 2.5, VA ECMO No UFH 25 U/ml (purge fluid) No Bridge to BIVAD and HTX
IMP3 CSMI (STEMI) Coronary perfusion, LV venting during ECMO IMPELLA 2.5, VA ECMO No IV bivalirudin No Organ donor (brain death)
IMP4 Cardiogenic shock LV venting during ECMO IMPELLA 2.5, VA ECMO No IV bivalirudin No Recovery
IMP5 Postcardiotomic cardiogenic shock (Sleeve procedure) Coronary perfusion, LV venting IMPELLA 2.5, VA ECMO, IABP Yes IV bivalirudin Yes Bridge to HTX
IMP6 CSMI (STEMI) Coronary perfusion, circulatory support IMPELLA 2.5, IABP No IV bivalirudin No Recovery
IMP7 Cardiogenic shock following percutaneous VT ablation Circulatory support, LV venting IMPELLA 2.5 No IV bivalirudin No Recovery
IMP8 Cardiogenic shock (coronary ischemia) Circulatory support IMPELLA CP, IABP No UFH 50 U/ml (purge fluid) Yes Death (MOF-withdrawal of care)
IMP9 CSMI (STEMI) Coronary perfusion, LV venting IMPELLA 2.5, VA ECMO No - No Death (MOF-withdrawal of care)
IMP10 CSMI (STEMI) Coronary perfusion, circulatory support, LV venting IMPELLA 2.5, IABP No UFH 50 U/ml (purge fluid) No Recovery
IMP11 CSMI (STEMI) Coronary perfusion, circulatory support IMPELLA 2.5, IABP No UFH 50 U/ml (purge fluid) No Recovery
IMP12 Postcardiotomic cardiogenic shock (LV aneurismectomy ) LV venting IMPELLA 2.5, VA ECMO Yes IV bivalirudin Yes Death (progressive cardiogenic shock)
IMP13 Postcardiotomic cardiogenic shock (CABG) Coronary perfusion, circulatory support IMPELLA CP, IABP No UFH 50 U/ml (purge fluid) No Recovery
IMP14 CSMI (STEMI) Coronary perfusion, LV venting IMPELLA 2.5, VA ECMO Yes IV bivalirudin No Death (MOF-withdrawal of care)
IMP15 Postcardiotomic cardiogenic shock (Mitral plasty) Coronary perfusion, circulatory support, LV venting IMPELLA 2.5, VA ECMO, IABP No IV bivalirudin No Recovery
IMP 16 CSMI (STEMI) Coronary perfusion, circulatory support IMPELLA 2.5, IABP No IV bivalirudin No Recovery
IMP 17 Cardiogenic shock (cronic myocarditis) Coronary perfusion, circulatory support IMPELLA 2.5, IABP Yes IV bivalirudin No Recovery
IMP18 Postcardiotomic cardiogenic shock (CABG) LV venting during VA ECMO IMPELLA 2.5, VA ECMO, IABP No UFH 25 U/ml (purge fluid) Yes Recovery
IMP 19 Cardiogenic shock (arrhytmia) Coronary perfusion, circulatory support, severe AI IMPELLA 2.5 No IV bivalirudin No Recovery
IMP 20 Cardiogenic shock (coronary artery disease) Coronary perfusion, circulatory support IMPELLA CP No IV bivalirudin No Recovery
IMP 21 Cardiogenic shock (chronic heart failure, multiple valvulopathy) LV venting during VA ECMO IMPELLA 2.5, VA ECMO, IABP Yes IV bivalirudin, UFH 25 U/ml (purge fluid) No Death (MOF-withdrawal of care)
IMP 22 CSMI (STEMI) Coronary perfusion, circulatory support, moderate AI IMPELLA CP Yes UFH 25 U/ml (purge fluid) No Recovery
  1. CSMI – cardiogenic shock myocardial infarction; STEMI – ST elevation myocardial infarction; VT – ventricular tachycardia; LV – left ventricle; VA ECMO – venoarterial extracorporeal membrane oxygenation; IABP – intraortic balloon pump; IV – intravenous; UFH – unfractionated heparin; VAD–ventricular assit device; HTX – heart transplantion